Sandra P. Reyna

4.2k citations

47 papers · 1.7k indexed · h-index 19

Genetics top 0.5%
Molecular Biology top 10%
Surgery top 5%
Genetics top 10%
Cardiology and Cardiovascular Medicine top 10%

Co-authors: Kathryn J. Swoboda Charles Scott Mark B. Bromberg Thomas W. Prior Kristin J. Krosschell John T. Kissel Thomas O. Crawford Mary Schroth
Topics: Neurogenetic and Muscular Disorders Research (39 papers)RNA modifications and cancer (18 papers)Congenital Anomalies and Fetal Surgery (15 papers)
Cited by: Genetics Surgery Molecular Biology
Journals: Journal of the American College of Cardiology PLoS ONE Neurology
Partner nations: United States Italy Canada

In The Last Decade

Sandra P. Reyna

44 papers receiving 1.7k citations

Peers

Countries citing papers authored by Sandra P. Reyna

Since Specialization

Citations

This map shows the geographic impact of Sandra P. Reyna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra P. Reyna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra P. Reyna more than expected).

Fields of papers citing papers by Sandra P. Reyna

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra P. Reyna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra P. Reyna. The network helps show where Sandra P. Reyna may publish in the future.

Co-authorship network of co-authors of Sandra P. Reyna

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra P. Reyna. A scholar is included among the top collaborators of Sandra P. Reyna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra P. Reyna. Sandra P. Reyna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Outcomes for patients in the RESTORE registry with spinal muscular atrophy and four or more SMN2 gene copies treated with onasemnogene abeparvovec 2024 ·European Journal of Paediatric Neurology ·Eduardo F. Tizzano,Susana Quijano-Roy,Laurent Servais,Julie Parsons,Sharon Aharoni,(unknown),Richard S. Finkel,Eugenio Mercuri,Janbernd Kirschner,Darryl C. De Vivo,Kayoko Saito,Dheeraj Raju,(unknown),Omar Dabbous,Nayla Mumneh,Sandra P. Reyna,(unknown)	0
2	Treatment preferences in spinal muscular atrophy: A swing weighting study for caregivers of patients with SMA types 1 and 2 2024 ·PLoS ONE ·Anish Patel,(unknown),(unknown),Yemi Oluboyede,Sylvaine Barbier,(unknown),Sandra P. Reyna,Omar Dabbous	0
3	Patients with Spinal Muscular Atrophy Type 1 Achieve and Maintain Bulbar Function Following Onasemnogene Abeparvovec Treatment 2023 ·Journal of Neuromuscular Diseases ·Katlyn McGrattan,(unknown),(unknown),Sally Dunaway Young,Eamonn O’Brien,Arseniy Lavrov,(unknown),(unknown),Sandra P. Reyna,Basil T. Darras	15
4	Safety of Onasemnogene Abeparvovec for Patients With Spinal Muscular Atrophy 8.5 kg or Heavier in a Global Managed Access Program 2022 ·Pediatric Neurology ·Deepa H. Chand,Susan L. Mitchell,Rui Sun,(unknown),Sandra P. Reyna,(unknown)	17
5	Real-world Outcomes of Nusinersen Alone and Onasemnogene Abeparvovec (OA) Alone or with Prior Nusinersen in Pediatric Patients with Spinal Muscular Atrophy (SMA): Interim Analysis of a US Retrospective Chart Review Study (P18-5.002) 2022 ·Neurology ·Omar Dabbous,Min Yang,(unknown),(unknown),(unknown),Anish Patel,(unknown),Sandra P. Reyna	1
6	Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy 2021 ·Drug Safety ·John Day,Jerry R. Mendell,Eugenio Mercuri,Richard S. Finkel,Kevin A. Strauss,A. de Kleyn,Sitra Tauscher‐Wisniewski,F Tukov,Sandra P. Reyna,Deepa H. Chand	81
7	Ambulation Status, Role Participation and Caregiver Assistance among Individuals with Spinal Muscular Atrophy Type III: Results from the 2018 Cure SMA Membership Survey (P1.6-061) 2019 ·Neurology ·Lisa Belter,Jill Jarecki,Rosángel Cruz,(unknown),Karen O’Brien,Sandra P. Reyna,(unknown),Angela D. Paradis	1
8	Spinal Muscular Atrophy (SMA) Subtype Concordance in Siblings: Findings From the Cure SMA Cohort 2019 ·Journal of Neuromuscular Diseases ·Cynthia C. Jones,Suzanne F. Cook,Jill Jarecki,Lisa Belter,Sandra P. Reyna,John F. Staropoli,Wildon Farwell,Kenneth Hobby	15
9	Safety and Efficacy of Nusinersen in Infants/Children with Spinal Muscular Atrophy (SMA): Part 1 of the Phase 2 EMBRACE Study (P2.324) 2018 ·Neurology ·Perry B. Shieh,Gyula Acsádi,Wolfgang Mueller‐Felber,Thomas O. Crawford,Randal Richardson,(unknown),Diana Castro,Sarah Gheuens,Ishir Bhan,Giulia Gambino,Peng Sun,Wildon Farwell,Sandra P. Reyna	2
10	Indirect estimation of the prevalence of spinal muscular atrophy Type I, II, and III in the United States 2017 ·Orphanet Journal of Rare Diseases ·Cathy Lally,Cynthia C. Jones,Wildon Farwell,Sandra P. Reyna,Suzanne F. Cook,W. Dana Flanders	63
11	The diagnostic utility of Sudoscan for distal symmetric peripheral neuropathy 2014 ·Journal of Diabetes and its Complications ·A. Gordon Smith,Margaret Lessard,Sandra P. Reyna,(unknown),J. Robinson Singleton	103
12	Reliability of the modified hammersmith functional motor scale in young children with spinal muscular atrophy 2011 ·Muscle & Nerve ·Kristin J. Krosschell,Charles Scott,Jo Anne Maczulski,Aga Lewelt,Sandra P. Reyna,Kathryn J. Swoboda,(unknown)	23
13	SMA CARNI-VAL TRIAL PART II: A Prospective, Single-Armed Trial of L-Carnitine and Valproic Acid in Ambulatory Children with Spinal Muscular Atrophy 2011 ·PLoS ONE ·John T. Kissel,Charles Scott,Sandra P. Reyna,Thomas O. Crawford,Louise R. Simard,Kristin J. Krosschell,Gyula Acsádi,(unknown),Mary Schroth,Guy D’Anjou,Bernard LaSalle,Thomas W. Prior,(unknown),Jo Anne Maczulski,Mark B. Bromberg,Gary M. Chan,Kathryn J. Swoboda,(unknown)	89
14	SMA CARNI-VAL Trial Part I: Double-Blind, Randomized, Placebo-Controlled Trial of L-Carnitine and Valproic Acid in Spinal Muscular Atrophy 2010 ·PLoS ONE ·Kathryn J. Swoboda,Charles Scott,Thomas O. Crawford,Louise R. Simard,Sandra P. Reyna,Kristin J. Krosschell,Gyula Acsádi,(unknown),Mary Schroth,Guy D’Anjou,Bernard LaSalle,Thomas W. Prior,(unknown),Jo Anne Maczulski,Mark B. Bromberg,Gary M. Chan,John T. Kissel,(unknown)	124
15	Compound muscle action potential and motor function in children with spinal muscular atrophy 2010 ·Muscle & Nerve ·Aga Lewelt,Kristin J. Krosschell,Charles Scott,Ai Sakonju,John T. Kissel,Thomas O. Crawford,Gyula Acsádi,Guy D’Anjou,Bakri Elsheikh,Sandra P. Reyna,Mary Schroth,Jo Anne Maczulski,Gregory J. Stoddard,Elie P. Elovic,Kathryn J. Swoboda	84
16	Phase II Open Label Study of Valproic Acid in Spinal Muscular Atrophy 2009 ·PLoS ONE ·Kathryn J. Swoboda,Charles Scott,Sandra P. Reyna,Thomas W. Prior,Bernard LaSalle,(unknown),Janine Wood,Gyula Acsádi,Thomas O. Crawford,John T. Kissel,Kristin J. Krosschell,Guy D’Anjou,Mark B. Bromberg,Mary Schroth,Gary M. Chan,Bakri Elsheikh,Louise R. Simard	132
17	C-Reactive Protein Predicts Death in Patients with Non-Ischemic Cardiomyopathy 2005 ·Cardiology ·Brianna S. Ronnow,Sandra P. Reyna,Joseph B. Muhlestein,Benjamin D. Horne,Chloe A. Allen Maycock,Tami L. Bair,John F. Carlquist,Abdallah G. Kfoury,Jeffrey L. Anderson,Dale G. Renlund	12
18	Natural history of denervation in SMA: Relation to age, SMN2 copy number, and function 2005 ·Annals of Neurology ·Kathryn J. Swoboda,Thomas W. Prior,Charles Scott,(unknown),(unknown),Sandra P. Reyna,Mark B. Bromberg	349
19	Which Features of the Metabolic Syndrome Predict the Prevalence and Clinical Outcomes of Angiographic Coronary Artery Disease? 2004 ·Cardiology ·Jeffrey L. Anderson,Benjamin D. Horne,(unknown),Sandra P. Reyna,John F. Carlquist,Tami L. Bair,Robert R. Pearson,Donald Lappé,Joseph B. Muhlestein	56
20	Is atrial fibrillation an inflammatory disease reflected by elevated C-reactive protein? 2003 ·Journal of the American College of Cardiology ·Chloe A. Allen Maycock,Donald Lappé,Brian G. Crandall,Joseph B. Muhlestein,Benjamin D. Horne,Tami L. Bair,Qunyu Li,Sandra P. Reyna,Dale G. Renlund,Jeffrey L. Anderson	4

About Sandra P. Reyna

Sandra P. Reyna is a scholar working on Genetics, Surgery and Molecular Biology, having authored 47 papers that have together received 1.7k indexed citations. Recurring topics across this work include Neurogenetic and Muscular Disorders Research (39 papers), RNA modifications and cancer (18 papers) and Congenital Anomalies and Fetal Surgery (15 papers). The work is most often cited by research in Genetics (1.2k citations), Surgery (725 citations) and Molecular Biology (984 citations). Sandra P. Reyna has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include Kathryn J. Swoboda, Charles Scott, Mark B. Bromberg, Thomas W. Prior, Kristin J. Krosschell, John T. Kissel, Thomas O. Crawford, Mary Schroth, Gyula Acsádi and Guy D’Anjou. Their work appears in journals such as Journal of the American College of Cardiology, PLoS ONE and Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact